Biography of Dr. Rezk Dr. Rezk is the founder of the clinical pharmacology and analytical chemistry core laboratory at The University of North Carolina at Chapel Hill, NC, USA. The laboratory core facility ranked as No. 1 clinical pharmacology laboratory nationally (USA) and internationally for innovation, quality of work and revenue (over $10,000,000). Dr. Rezk’s discoveries had led to the start of the new field of HIV-prevention. Dr. Rezk’s honors include; the UNC Chancellor’s award for innovation in science, and the State of North Carolina Governor’s award for innovation in science, the highest prestigious scientific award in the state of North Carolina can be achieved. He acts as the PI for many HIV-research projects. Dr. Rezk published thirty-nine papers in reputed journals, three web scientific technical articles, and thirty-eight scientific abstracts. Dr. Rezk has planned and established Saudi National Research Laboratories and a BE/BA center at the Saudi National Guard in Riyadh, KSA. His research interests include innovation in bio-analytical chemistry clinical pharmacology and clinical toxicology. Currently, Dr. Rezk works consultant to Andor Labs in Durham, NC, as an owner and research & development (R&D) director; strategically planning to expand the company’s services with matchless experience. Recently Dr. Rezk has joined Taibah University, Al-Madinah, Saudi Arabia as an Associate Professor. Likely as a new faculty, he will teach toxicology/pharmacology and research methodology courses and establish new research lines to fit with University mission and his background.